154
Views
9
CrossRef citations to date
0
Altmetric
Reviews

Advances in predicting CYP-mediated drug interactions in the drug discovery setting

, , &
Pages 677-691 | Published online: 07 Dec 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jianling Wang, Laszlo Urban & Dejan Bojanic. (2007) Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety. Expert Opinion on Drug Metabolism & Toxicology 3:5, pages 641-665.
Read now

Articles from other publishers (8)

William M. Atkins. (2019) Mechanisms of promiscuity among drug metabolizing enzymes and drug transporters. The FEBS Journal 287:7, pages 1306-1322.
Crossref
Jan Wahlstrom & Larry Wienkers. 2020. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology 847 866 .
Jan Wahlstrom & Larry Wienkers. 2018. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology 1 20 .
Katharina Neufeld, Sonja Meyer zu Berstenhorst & Jörg Pietruszka. (2014) Evaluation of coumarin-based fluorogenic P450 BM3 substrates and prospects for competitive inhibition screenings. Analytical Biochemistry 456, pages 70-81.
Crossref
Brooke M. VandenBrink, Robert S. Foti, Dan A. Rock, Larry C. Wienkers & Jan L. Wahlstrom. (2011) Evaluation of CYP2C8 Inhibition In Vitro: Utility of Montelukast as a Selective CYP2C8 Probe Substrate. Drug Metabolism and Disposition 39:9, pages 1546-1554.
Crossref
Robert S. Foti, Dan A. Rock, Larry C. Wienkers & Jan L. Wahlstrom. (2010) Selection of Alternative CYP3A4 Probe Substrates for Clinical Drug Interaction Studies Using In Vitro Data and In Vivo Simulation. Drug Metabolism and Disposition 38:6, pages 981-987.
Crossref
Dil M. Ramanathan & Richard M. Lelacheur. 2008. Mass Spectrometry in Drug Metabolism and Pharmacokinetics. Mass Spectrometry in Drug Metabolism and Pharmacokinetics 1 85 .
Jianling Wang, Laszlo Urban & Dejan Bojanic. (2007) Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety . Expert Opinion on Drug Metabolism & Toxicology 3:5, pages 641-665.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.